ACIP Updates Influenza Vaccine Guidelines for Seniors
The Advisory Committee on Immunization Practices (ACIP) for the U.S. Centers for Disease Control and Prevention (CDC) has issued new updates for influenza vaccines for 2020–2021 “flu season,” primarily for Fluzone and Fluad vaccines. In November 2019, U.S. Food and Drug Administration (FDA) licensed inactivated injectable Fluzone High-Dose Quadrivalent (HD-IIV4) for use in persons aged […]
CDC Reduces COVID-19 Fatality Rate to 0.26 Percent
In a new document providing guidance for public health officials on COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) estimates the infection fatality rate (IFR) for the disease at 0.4 percent, or about half the nearly one percent fatality rate the CDC estimated in March 2020 when it was predicting up to 1.7 […]
Coronavirus Mortality Rate Could Drop
Health experts say the mortality rate of the coronavirus will likely drop as more is learned about the virus and more cases are accounted for. On Tuesday, the World Health Organization’s director general said, globally, about 3.4 percent of reported COVID-19 cases have died. By comparison, seasonal flu generally kills far fewer than one percent […]
Is a Bill Requiring Your Children to Get Every CDC Recommended Vaccination Coming to Your State?
As vaccine-related bills are being introduced into state legislatures this month, a bill (HB1090) has been proposed in the Virginia legislature to require school children to receive every dose of all current and future vaccines added to the recommended childhood vaccine schedule by the Advisory Committee on Immunization Practices (ACIP) appointed by the U.S. Centers […]
Higher Humidity in Buildings Can Help Lower Infections
Harvard Medical School graduate and pediatric oncologist Stephanie Taylor, MD once took care of children with cancer at a teaching hospital. She wondered why many of her young patients contracted infections, such as influenza, despite the hospital’s heavy emphasis on prevention. Taylor began to suspect increased susceptibility to contracting infections might have something to do […]
Novartis Manipulated Data in FDA Biologics License Application
On Aug. 6, 2019, the U.S. Food and Drug Administration (FDA) issued a statement saying that Swiss pharmaceutical company Novartis AG submitted a biologics license application (BLA) for the spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec-xioi) with manipulated data and failed to inform regulators until June 28, 2019—more than a month after the […]
